Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on February 21, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,212 cr
Turnover Ratio 28.44%
Expense Ratio 0.72%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: -7.70%
  • 1Y: 10.52%
  • 3M: -6.23%
  • 3Y: 20.78%
  • 6M: -8.00%
  • 5Y: 23.96%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since almost 4 years) Rajat Srivastava (Since 5 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 33.76
P/B Ratio 5.09
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 3.71
Beta 0.92
R-Squared 96.98
Info Ratio 1.17
Tracking Err 2.97
Sortino 1.884
Sharpe 0.971
Std Dev 15.483
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.32%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.68%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
37.690 16.76% 4,918 cr 1.1% -
29.424 14.76% 84 cr 1.22% -
447.542 14.21% 3,522 cr 0.89% -
31.834 10.52% 1,212 cr 0.72% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata